Login with your work email address to view charts. No credit card required.
| Art Unit: | 1654 — Drug, bio-affecting and body treating compositions |
|---|---|
| Group: | 1650 — Enzymology, Microbiology, and Fermentation, Small Peptides and Bioacting Plant, Microbial and Animal Extracts |
| Classes: |
514 — Drug, bio-affecting and body treating compositions 530 — Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof 424 — Drug, bio-affecting and body treating compositions 435 — Chemistry: molecular biology and microbiology 604 — Surgery 436 — Chemistry: analytical and immunological testing |
| Phone: | (571) 272-2836 |
| Email: | kristina.hellman@uspto.gov |
| Location: | VA 22314 |
| Title: | Pat Examnr (Biolgy) |
| Service: | 14 years |
| Grade: | GS-13 |
| 3-Year Grant rate: | 60% over 381 cases |
|---|---|
| Difficulty: | Harder |
| Difficulty Percentile: | 72nd
|
With Examiner Hellman, you have a 60% chance of getting an issued patent by 3 years after the first office action. Examiner Hellman is a harder examiner and in the 72nd percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Hellman, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Hellman's grant rate is higher than that of Art Unit 1654 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Hellman | 1.6 |
| Art Unit 1654 | 1.7 |
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.